AP-1 Mediates Cellular Adaptation and Memory Formation During Therapy Resistance
Li, J.; Ravindran, P. T.; O'Farrell, A.; Busch, G. T.; Boe, R. H.; Niu, Z.; Woo, S.; Dunagin, M. C.; Jain, N.; Goyal, Y.; Sarma, K.; Herlyn, M.; Raj, A.
Show abstract
Cellular responses to environmental stimuli are typically thought to be governed by genetically encoded programs. We demonstrate that melanoma cells can form and maintain cellular memories during the acquisition of therapy resistance that exhibit characteristics of cellular learning and are dependent on the transcription factor AP-1. We show that cells exposed to a low dose of therapy adapt to become resistant to a high dose, demonstrating that resistance was not purely selective. The application of therapy itself results in the encoding of transient gene expression into cellular memory and that this encoding occurs for both transiently induced and probabilistically arising expression. Chromatin accessibility showed concomitant persistence. A two-color AP-1 reporter system showed that these memories are encoded in cis, constituting an example of activating cis epigenetics. Our findings establish the formation and maintenance of cellular memories as a critical aspect of gene regulation during the development of therapy resistance.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures 98%
- A recurrent pathogenic BRCA2 truncating variant reveals a role for BRCA2-PCAF complex in modulating NF-κB-driven transcription 96%
- Multiplexed single-cell profiling of post-perturbation transcriptional responses to define cancer vulnerabilities and therapeutic mechanism of action 96%
Similar papers in this journal
- Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies. 95%
- A curative combination therapy for lymphomas achieves high fractional cell killing through low cross-resistance and drug additivity but not synergy 95%
- The transcriptomic response of cells to a drug combination is more than the sum of the responses to the monotherapies 95%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- The G1/S transition is promoted by Rb degradation via the E3 ligase UBR5 96%
- ATR safeguards replication forks against APOBEC3B-induced toxic PARP1 trapping 95%
- Select EZH2 inhibitors enhance the viral mimicry effects of DNMT inhibition through a mechanism involving calcium-calcineurin-NFAT signaling 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.